Access Program Information
The purpose of this compassionate use study, for two patients with thrombotic
microangiopathy, is to provide expanded access to patients who have participated in the
clinical trial OMS721-TMA-001 and in whom improvement in their disease markers was observed
while on treatment or to patients who could otherwise benefit from the treatment. This is a
treatment protocol; not a research protocol.Therefore, only patients in study OMS721-TMA-001
deemed eligible by the investigator may participate.